Answers are grounded in this paper and cite their sources.
Cross-sectional analysis evaluated serum magnesium levels in AMI patients, highlighting their connection to complications and outcomes.
Background: Hypomagnesemia has been increasingly recognized as an independent risk factor for cardiovascular mortality in acute myocardial infarction (AMI). Early identification of patients with low serum magnesium levels may help predict clinical outcomes and guide therapeutic interventions. Objective: To evaluate serum magnesium concentrations in patients with acute myocardial infarction and assess their correlation with early complications and clinical outcomes. Methods: A hospital-based cross-sectional study was conducted at JJM Medical College, Davangere, including patients aged >30 years with confirmed AMI. Serum magnesium levels were measured daily during hospitalization. Statistical analysis was performed to correlate magnesium levels with complications including arrhythmias, cardiogenic shock, and mortality. Results: The study of 100 patients demonstrated an inverse correlation between serum magnesium levels and complications in AMI patients. Mean serum magnesium levels were lower in patients with complications compared to those without (1.4±0.2 vs 2.1±0.3 mg/dL, p<0.05). Patients with combined arrhythmia and shock showed the lowest mean magnesium levels (1.1±0.2 mg/dL), suggesting a possible dose-response relationship. Overall complication rate was 42%, with hypomagnesemia present in 45% of patients. Conclusion: Low serum magnesium levels serve as an important prognostic marker in acute myocardial infarction. Hypomagnesemia correlates with increased incidence of arrhythmias, cardiogenic shock, and mortality, making serum magnesium a valuable predictor of clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: